About us
history
Company history
Engaged in health food R&D and sales in June 2010
In March 2020, the company invested in the production of its own brand "Power 100" immune nutrition formula.
March 1, 2013. Signed an industry-university agreement with the Kaohsiung Medical University Operations Office
2. In July of the same year, the "Power 100" immune nutrition formula was completed to assist in improving the period of cancer chemotherapy.
Immune function effect evaluation experiment
In January 2014, we conducted an oncogene mouse immune control experiment with the Institute of Cancer Biology of China Medical University.
In April 2014, Protekt Biomedical Technology Co., Ltd. was established
Nubio Biotechnology Co., Ltd. was established in June 2014
In March 2020, the company invested in the production of its own brand "Power 100" immune nutrition formula.
March 1, 2013. Signed an industry-university agreement with the Kaohsiung Medical University Operations Office
2. In July of the same year, the "Power 100" immune nutrition formula was completed to assist in improving the period of cancer chemotherapy.
Immune function effect evaluation experiment
In January 2014, we conducted an oncogene mouse immune control experiment with the Institute of Cancer Biology of China Medical University.
In April 2014, Protekt Biomedical Technology Co., Ltd. was established
Nubio Biotechnology Co., Ltd. was established in June 2014
R&D capabilities
INNOVATION
The core technology of AlphaBio Biotech independent research primarily involves utilizing the polysaccharide components of microorganisms. This can induce the production of specific pathway cytokines within patients' bodies, prompting the differentiation of immune responses towards pathways beneficial for clinical treatment.
>Research and evaluation capabilities in immune cell differentiation
>Control over research and evaluation of immune cell differentiation
>Ability to control immune cell differentiation through immunonutrition and develop integrated applications
>Application of techniques for controlling tumor-infiltrating lymphocytes
>Research and evaluation capabilities in immune cell differentiation
>Control over research and evaluation of immune cell differentiation
>Ability to control immune cell differentiation through immunonutrition and develop integrated applications
>Application of techniques for controlling tumor-infiltrating lymphocytes
business philosophy
Business philosophy
We provide customers with overall health food research and development planning, and can manufacture powder and jelly health foods for customers, and maintain stable quality management. Our technology and capabilities have been deeply recognized by customers.
Safety ensures high quality and creates good health and physical strength
